Hematology and Oncology Division and Radiology Department, Boston Children's Hospital, Boston, MA, USA.
Radiology Department, University of Massachusetts Medical School, Worcester, MA, USA.
Eur J Neurol. 2019 Oct;26(10):1341-1344. doi: 10.1111/ene.13959. Epub 2019 May 2.
Adrenomyeloneuropathy (AMN) is the most frequent metabolic hereditary spastic paraplegia. Accordingly, its main site of pathological changes is the spinal cord. It is difficult to quantify AMN progression because commonly used clinical scales have limitations and reliable biomarkers are lacking. The goal was to investigate whether spinal cord and brain quantitative magnetic resonance imaging may assess structural changes in AMN over a relatively short time period.
In this longitudinal observational study, the total cord areas (TCAs) from the C2-C3 to T2-T3 level and diffusion tensor imaging (DTI) metrics of the cervical spinal cord and brain portion of the corticospinal tracts in six AMN and six age-matched control subjects at baseline and at a mean follow-up of 22.6 months were assessed.
A significant reduction of the mean TCA at the T1-T2 level (-3.79%) and a trend of reduction at the lowest cervical levels were observed only in AMN patients. Additionally, DTI metrics revealed significant changes in fractional anisotropy (-8.84%), mean diffusivity (+12.62%) and radial diffusivity (+25.91%) at the C2-C3 level.
The study encourages the assessment of TCAs and spinal cord DTI metrics as surrogate outcome measures in AMN, by focusing on the cervical-thoracic junction and the uppermost part of the cervical spinal cord. Despite the limitation of the results due to the small number of investigated subjects, these observations are useful for forthcoming clinical trials in AMN and possibly other hereditary diseases with predominant spinal cord involvement.
肾上腺脑白质营养不良(AMN)是最常见的代谢性遗传性痉挛性截瘫。因此,其主要病变部位是脊髓。由于常用的临床量表存在局限性,且缺乏可靠的生物标志物,因此难以量化 AMN 的进展。本研究旨在探讨脊髓和脑定量磁共振成像(MRI)是否可在相对较短的时间内评估 AMN 的结构变化。
在这项纵向观察性研究中,我们在基线时和平均 22.6 个月时评估了 6 例 AMN 患者和 6 例年龄匹配的对照者的颈髓 C2-C3 至 T2-T3 水平的总脊髓面积(TCAs)和脑部分皮质脊髓束的扩散张量成像(DTI)指标。
仅在 AMN 患者中观察到 T1-T2 水平的平均 TCA 显著降低(-3.79%),且在最低颈椎水平有降低的趋势。此外,DTI 指标显示 C2-C3 水平的各向异性分数(-8.84%)、平均弥散度(+12.62%)和径向弥散度(+25.91%)均有显著变化。
本研究通过关注颈胸交界处和颈髓上部,鼓励将 TCAs 和脊髓 DTI 指标评估作为 AMN 的替代终点测量指标。尽管由于研究对象数量较少,结果存在一定局限性,但这些观察结果对于 AMN 以及可能其他以脊髓受累为主的遗传性疾病的未来临床试验具有一定的应用价值。